Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: J Thorac Oncol. 2021 Jul 6;16(11):1925–1935. doi: 10.1016/j.jtho.2021.06.014

Table 3.

Survival analysis of PD patients

Adverse factor HR 95% CI p-value
Univariable analysis of pre-operative characteristics (N=193, 165 deaths)
MPT poor risk 1.28 0.87–1.88 0.212
Molecular cluster non-E 1.66 1.15–2.41 0.007
NLR >3 1.54 1.13–2.11 0.007
TV >200 cc* 1.59 1.16–2.19 0.004
Multivariable analysis of pre-operative characteristics (N=193, 165 deaths)
MPT poor risk & TV >200 cc 2.51 1.44–4.38 <0.001
Molecular cluster non-E 1.58 1.08–2.31 0.017
NLR >3 1.50 1.09–2.06 0.013
ECOG performance status 1–2 1.53 1.07–2.71 0.017
Serum albumin ≥43 g/L 1.68 1.70–2.64 0.023
*

TV missing for 1 patient